An agent that activates natural killer cells and is useful in renal cell carcinoma is :
Recombinant IL-2 (aldesleukin) is used for the treatment of malignant melanoma and renal cell carcinoma.
Aldesleukin
Etanercept
Leflunomide
Thalidomide